ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects

ClinicalTrials.gov ID: NCT01764386

Public ClinicalTrials.gov record NCT01764386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open-Label, Controlled, Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (The Ignite Study)

Study identification

NCT ID
NCT01764386
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Orexigen Therapeutics, Inc
Industry
Enrollment
242 participants

Conditions and interventions

Interventions

  • CLI Behavioral
  • NB Drug
  • Usual Care Behavioral

Behavioral · Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Aug 31, 2014
Completion
Aug 31, 2014
Last update posted
Dec 28, 2015

2013 – 2014

United States locations

U.S. sites
15
U.S. states
8
U.S. cities
15
Facility City State ZIP Site status
Radiant Research Denver Colorado 80239
Radiant Research, Inc. St Louis Missouri 63151
PMG Research of Raleigh Cary North Carolina 27518
PMG Research of Winston-Salem Hickory North Carolina 28601
PMG Research of Raleigh Raleigh North Carolina 27609
PMG Research of Salisbury Salisbury North Carolina 28144
PMG Research of Wilmington, LLC Wilmington North Carolina 28401
Radiant Research-Akron Akron Ohio 44311
Radiant Research, Inc. Columbus Ohio 43212
Radiant Research Anderson South Carolina 29621
Radiant Research, Greer Greer South Carolina 29651
PMG Research of Charleston Mt. Pleasant South Carolina 29464
PMG Research of Bristol Bristol Tennessee 37620
Radiant Research Dallas-North Dallas Texas 75231
Radiant Research, SLC Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01764386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 28, 2015 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01764386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →